@Propheteus Exactly, but apparently they are trying to anchor themselves in the US and don't want to lose market share, and it would also be advantageous for oral drugs. The same applies to Europe with the takeover. I think it would benefit both. Let's see how the cat and mouse game plays out.
@Aktienfox I agree and it also makes sense for the faster distribution of the products, especially the oral medication, before $LLY gains a foothold here, as the product is unlikely to be changed so quickly if it is well tolerated and accepted.
